Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 214

    1.

    Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1).

    Searles Nielsen S, Mueller BA, De Roos AJ, Viernes HM, Farin FM, Checkoway H.

    Environ Health Perspect. 2005 Jul;113(7):909-13.PMID: 16002382 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.

    Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J.

    Arch Neurol. 2004 Mar;61(3):351-6.PMID: 15023811 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.

    Mackness B, Durrington P, Povey A, Thomson S, Dippnall M, Mackness M, Smith T, Cherry N.

    Pharmacogenetics. 2003 Feb;13(2):81-8.PMID: 12563177 [PubMed - indexed for MEDLINE]Related articles

    4.

    Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.

    Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ.

    Neurotoxicology. 1998 Aug-Oct;19(4-5):645-50.PMID: 9745924 [PubMed - indexed for MEDLINE]Related articles

    5.

    Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population.

    Huang Q, Liu YH, Yang QD, Xiao B, Ge L, Zhang N, Xia J, Zhang L, Liu ZJ.

    Neurol Res. 2006 Jul;28(5):549-54.PMID: 16808888 [PubMed - indexed for MEDLINE]Related articles

    6.

    A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.

    Morahan JM, Yu B, Trent RJ, Pamphlett R.

    Neurotoxicology. 2007 May;28(3):532-40. Epub 2006 Nov 26.PMID: 17204329 [PubMed - indexed for MEDLINE]Related articles

    7.

    Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon.

    O'Leary KA, Edwards RJ, Town MM, Boobis AR.

    Pharmacogenet Genomics. 2005 Jan;15(1):51-60.PMID: 15864126 [PubMed - indexed for MEDLINE]Related articles

    8.

    Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions.

    D'Amelio M, Ricci I, Sacco R, Liu X, D'Agruma L, Muscarella LA, Guarnieri V, Militerni R, Bravaccio C, Elia M, Schneider C, Melmed R, Trillo S, Pascucci T, Puglisi-Allegra S, Reichelt KL, Macciardi F, Holden JJ, Persico AM.

    Mol Psychiatry. 2005 Nov;10(11):1006-16.PMID: 16027737 [PubMed - indexed for MEDLINE]Related articles

    9.

    Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.

    Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, Richter RJ, Costa LG, Furlong CE.

    Pharmacogenet Genomics. 2005 Aug;15(8):589-98.PMID: 16007003 [PubMed - indexed for MEDLINE]Related articles

    10.

    New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

    Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT.

    J Natl Cancer Inst. 2003 Jun 4;95(11):812-8.PMID: 12783936 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Farm and animal exposures and pediatric brain tumors: results from the United States West Coast Childhood Brain Tumor Study.

    Holly EA, Bracci PM, Mueller BA, Preston-Martin S.

    Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):797-802.PMID: 9752988 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

    Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE.

    Biomarkers. 2003 Jan-Feb;8(1):1-12. Review.PMID: 12519632 [PubMed - indexed for MEDLINE]Related articles

    13.

    Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure.

    Hernández AF, Mackness B, Rodrigo L, López O, Pla A, Gil F, Durrington PN, Pena G, Parrón T, Serrano JL, Mackness MI.

    Hum Exp Toxicol. 2003 Nov;22(11):565-74.PMID: 14686479 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

    Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan ML, Allayee H, Lusis AJ, Hazen SL.

    JAMA. 2008 Mar 19;299(11):1265-76.PMID: 18349088 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Polymorphisms of the paraoxonase gene and risk of preterm delivery.

    Chen D, Hu Y, Chen C, Yang F, Fang Z, Wang L, Li J.

    Epidemiology. 2004 Jul;15(4):466-70.PMID: 15232408 [PubMed - indexed for MEDLINE]Related articles

    16.

    Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.

    Clarimon J, Eerola J, Hellström O, Tienari PJ, Singleton A.

    Neurosci Lett. 2004 Sep 2;367(2):168-70.PMID: 15331145 [PubMed - indexed for MEDLINE]Related articles

    17.

    Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.

    Costa LG, Cole TB, Vitalone A, Furlong CE.

    Clin Chim Acta. 2005 Feb;352(1-2):37-47. Review.PMID: 15653099 [PubMed - indexed for MEDLINE]Related articles

    18.

    Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.

    Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O.

    Clin Biochem. 2008 Jan;41(1-2):1-9. Epub 2007 Aug 24.PMID: 17920578 [PubMed - indexed for MEDLINE]Related articles

    19.

    Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.

    Cronin S, Greenway MJ, Prehn JH, Hardiman O.

    J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):984-6.PMID: 17702780 [PubMed - indexed for MEDLINE]Related articles

    20.

    Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.

    Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T.

    Chem Biol Interact. 2007 Jul 20;168(3):184-92. Epub 2007 Apr 21.PMID: 17532308 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data